Data / Form D filings / Intelomed, Inc.
Intelomed, Inc.: Form D filings
Intelomed, Inc., a biotechnology company in Pittsburgh, PA, filed 8 Form D notices with the SEC between 2010 and 2017. The latest, on January 9, 2017, reports $502,429 sold of a $1.5 million offering to 10 investors.
Find out what Intelomed, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- PINE CORPORATE CENTER 3, 6041 WALLACE ROAD EXT, SUITE 110, Pittsburgh, PA, 15090
- Phone
- (855) 279-0551
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1482781
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 9, 2017 | New notice | $1,500,000 | $502,429 | $997,571 | 10 | Dec 23, 2016 | sec.gov |
| Jan 29, 2016 | Amendment | $5,000,000 | $1,855,410 | $3,144,590 | 8 | Jan 21, 2016 | sec.gov |
| Jan 27, 2016 | New notice | $5,000,000 | $1,855,410 | $3,144,590 | 8 | Jan 21, 2016 | sec.gov |
| Jul 23, 2014 | New notice | $3,846,926 | $3,846,926 | $0 | 29 | Jul 15, 2014 | sec.gov |
| Sep 10, 2013 | New notice | $2,500,000 | $2,404,582 | $95,418 | 22 | Sep 9, 2013 | sec.gov |
| Dec 5, 2012 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
| May 24, 2011 | New notice | $3,000,000 | $2,611,000 | $389,000 | 15 | May 13, 2011 | sec.gov |
| Feb 1, 2010 | New notice | $500,000 | $200,000 | $300,000 | 1 | Jan 25, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jill F. Schiaparelli | Executive Officer, Director | |
| William P. Malloy | Director | |
| Ned Laubacher | Director | |
| Michael Stephen Dignazio | Executive Officer | |
| Mark P. Rossi | Director | |
| R. Stephen Doyle | Director |
Other biotechnology companies in Pennsylvania that filed recently
- Traws Pharma, Inc. offering · Nov 5, 2026
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
- Merlin Biotech, Inc. $50,000 · Aug 11, 2026
Every Form D from the week of Jan 9, 2017 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Intelomed, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.